As of 4:02pm ET
| +0.04 / +0.73%|
The 3 analysts offering 12-month price forecasts for Medgenics Inc have a median target of 13.00, with a high estimate of 14.50 and a low estimate of 12.00. The median estimate represents a +134.23% increase from the last price of 5.55.
The current consensus among 3 polled investment analysts is to Buy stock in Medgenics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.